Pascal H P de Jong

Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial

Doortje I Krijbolder, Marloes Verstappen, Bastiaan T van Dijk et al. · The Lancet · 2022 · 173 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +12

Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in patients with rheumatoid arthritis

Maurits C. F. J. de Rotte, Ethan den Boer, Pascal H P de Jong et al. · Annals of the Rheumatic Diseases · 2013 · 91 citations

Medicine, Clinical Sciences, Pharmacology +14

Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study

Elise van Mulligen, Pascal H P de Jong, T. Martijn Kuijper et al. · Annals of the Rheumatic Diseases · 2019 · 64 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

An ultrastructural study of chromate-induced hyperplasia in the gill of rainbow trout (Salmo gairdneri)

J.H.M. Temmink, P.J. Bouwmeister, Pascal H P de Jong et al. · Aquatic Toxicology · 1983 · 61 citations

Life Sciences, Zoology, Fish Biology +11

Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis

Maurits C. F. J. de Rotte, Saskia M. F. Pluijm, Pascal H P de Jong et al. · PLoS ONE · 2018 · 60 citations · Full text

Medicine, Translational Sciences, Clinical Epidemiology +16